Low Liver Density Is Linked to Cardiovascular Comorbidity in COPD: An ECLIPSE Cohort Analysis

References

• Lee -CT-C, Mao I-C, Lin C-H, Lin S-H, Hsieh M-C. Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study. Eur J Clin Invest. 2013;43(11):1113–1119. doi:10.1111/eci.1214724028296
   PubMed Web of Science ®Google Scholar
• Onishi K. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease. J Cardiol. 2017;70(2):128–134. doi:10.1016/j.jjcc.2017.03.00128325523
   PubMed Web of Science ®Google Scholar
• Pistelli R, Lange P, Miller DL. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. Eur Respir J Suppl. 2003;40:10s–14s. doi:10.1183/09031936.03.0040340312762568
   PubMedGoogle Scholar
• Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128(4):2640–2646. doi:10.1378/chest.128.4.264016236937
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.0013380517138679
   PubMed Web of Science ®Google Scholar
• Wouters EFM. Obesity and metabolic abnormalities in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2017;14(Supplement_5):S389–S394. doi:10.1513/AnnalsATS.201705-371AW29161076
   PubMed Web of Science ®Google Scholar
• Reccia I, Kumar J, Akladios C, et al. Non-alcoholic fatty liver disease: a sign of systemic disease. Metab Clin Exp. 2017;72:94–108. doi:10.1016/j.metabol.2017.04.01128641788
   PubMed Web of Science ®Google Scholar
• Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20(7):1724–1745. doi:10.3748/wjg.v20.i7.172424587651
   PubMed Web of Science ®Google Scholar
• Liu H, Lu H-Y. Nonalcoholic fatty liver disease and cardiovascular disease. World J Gastroenterol. 2014;20(26):8407–8415. doi:10.3748/wjg.v20.i26.840725024598
   PubMed Web of Science ®Google Scholar
• Perazzo H, Poynard T, Dufour J-F. The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. Clin Liver Dis. 2014;18(1):233–248. doi:10.1016/j.cld.2013.09.01424274877
   PubMed Web of Science ®Google Scholar
• Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol Res. 2016;46(11):1074–1087. doi:10.1111/hepr.1265626785389
   PubMed Web of Science ®Google Scholar
• van den Borst B, Gosker HR, Schols AMWJ. Central fat and peripheral muscle: partners in crime in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(1):8–13. doi:10.1164/rccm.201208-1441OE23281350
   PubMed Web of Science ®Google Scholar
• Minville C, Hilleret M-N, Tamisier R, et al. Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. Chest. 2014;145(3):525–533. doi:10.1378/chest.13-093824264333
   PubMed Web of Science ®Google Scholar
• Aron-Wisnewsky J, Clement K, J-L P. Nonalcoholic fatty liver disease and obstructive sleep apnea. Metab Clin Exp. 2016;65(8):1124–1135. doi:10.1016/j.metabol.2016.05.00427324067
   PubMed Web of Science ®Google Scholar
• Nascimbeni F, Ballestri S, Machado MV, et al. Clinical relevance of liver histopathology and different histological classifications of NASH in adults. Expert Rev Gastroenterol Hepatol. 2018;12(4):351–367. doi:10.1080/17474124.2018.141575629224471
   PubMed Web of Science ®Google Scholar
• Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006;239(1):105–112. doi:10.1148/radiol.239105036116484355
   PubMed Web of Science ®Google Scholar
• Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol. 2007;188(5):1307–1312. doi:10.2214/AJR.06.099217449775
   PubMed Web of Science ®Google Scholar
• Boyce CJ, Pickhardt PJ, Kim DH, et al. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol. 2010;194(3):623–628. doi:10.2214/AJR.09.259020173137
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008;31(4):869–873. doi:10.1183/09031936.0011170718216052
   PubMed Web of Science ®Google Scholar
• Agusti A, Calverley PMA, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122. doi:10.1186/1465-9921-11-12220831787
   PubMed Web of Science ®Google Scholar
• Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365(13):1184–1192. doi:10.1056/NEJMoa110548221991892
   PubMed Web of Science ®Google Scholar
• Davidson LE, Kuk JL, Church TS, Ross R. Protocol for measurement of liver fat by computed tomography. J Appl Physiol. 2006;100(3):864–868. doi:10.1152/japplphysiol.00986.200516293702
   PubMed Web of Science ®Google Scholar
• Martin M, Almeras N, Després J-P, et al. Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy. Int J Chron Obstruct Pulmon Dis. 2017;12:451–460. doi:10.2147/COPD.S12475028203068
   PubMed Web of Science ®Google Scholar
• Moon SW, Kim SY, Jung JY, et al. Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: korea National Health and Nutrition Examination Survey, 2007–2010. Int J Chron Obstruct Pulmon Dis. 2018;13:2603–2611. doi:10.2147/COPD.S16690230214178
   PubMed Web of Science ®Google Scholar
• Viglino D, Jullian-Desayes I, Minoves M, et al. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. Eur Respir J. 2017;49:6. doi:10.1183/13993003.01923-2016
   Web of Science ®Google Scholar
• Viglino D, Plazanet A, Bailly S, et al. Impact of non-alcoholic fatty liver disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease. Sci Rep. 2018;8(1):16559. doi:10.1038/s41598-018-34988-230410123
   PubMed Web of Science ®Google Scholar
• Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389–397.e10. doi:10.1053/j.gastro.2015.04.04325935633
   PubMed Web of Science ®Google Scholar
• Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589–600. doi:10.1016/j.jhep.2016.05.01327212244
   PubMed Web of Science ®Google Scholar
• Speliotes EK, Massaro JM, Hoffmann U, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010;51(6):1979–1987. doi:10.1002/hep.2359320336705
   PubMed Web of Science ®Google Scholar
• Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686–690. doi:10.1038/nrgastro.2013.17124042449
   PubMed Web of Science ®Google Scholar
• Tapper EB, Loomba R. Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. Nat Rev Gastroenterol Hepatol. 2018;15(5):274–282. doi:10.1038/nrgastro.2018.1029463906
   PubMed Web of Science ®Google Scholar
• Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2014;20(2):475–485. doi:10.3748/wjg.v20.i2.47524574716
   PubMed Web of Science ®Google Scholar
• Tapper EB, Sengupta N, Hunink MGM, Afdhal NH, Lai M. Cost-effective evaluation of nonalcoholic fatty liver disease with NAFLD fibrosis score and vibration controlled transient elastography. Am J Gastroenterol. 2015;110(9):1298–1304. doi:10.1038/ajg.2015.24126303130
   PubMed Web of Science ®Google Scholar
• Munteanu M, Ratziu V, Morra R, Messous D, Imbert-Bismut F, Poynard T. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: fibroTest-FibroMax experience. J Gastrointestin Liver Dis. 2008;17(2):187–191.18568141
   PubMed Web of Science ®Google Scholar
• Hashimoto E, Taniai M, Tokushige K. Characteristics and diagnosis of NAFLD/NASH. J Gastroenterol Hepatol. 2013;28(Suppl 4):64–70. doi:10.1111/jgh.1227124251707
   PubMed Web of Science ®Google Scholar
• Halvorsen RA, Korobkin M, Ram PC, Thompson WM. CT appearance of focal fatty infiltration of the liver. AJR Am J Roentgenol. 1982;139(2):277–281. doi:10.2214/ajr.139.2.2776979879
   PubMed Web of Science ®Google Scholar
• Kammen BF, Pacharn P, Thoeni RF, et al. Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. AJR Am J Roentgenol. 2001;177(5):1035–1039. doi:10.2214/ajr.177.5.177103511641164
   PubMed Web of Science ®Google Scholar
• Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther. 2017;34(6):1291–1326. doi:10.1007/s12325-017-0556-128526997
   PubMed Web of Science ®Google Scholar
• Du T, Sun X, Yuan G, et al. Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors. Nutr Metab Cardiovasc Dis. 2017;27(1):63–69. doi:10.1016/j.numecd.2016.10.00427956025
   PubMed Web of Science ®Google Scholar
• Jaruvongvanich V, Sanguankeo A, Riangwiwat T, Testosterone US. Sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann Hepatol. 2017;16(3):382–394. doi:10.5604/16652681.123548128425408
   PubMed Web of Science ®Google Scholar
• Palmisano BT, Zhu L, Stafford JM. Role of estrogens in the regulation of liver lipid metabolism. Adv Exp Med Biol. 2017;1043:227–256. doi:10.1007/978-3-319-70178-3_1229224098
   PubMed Web of Science ®Google Scholar
• Toshikuni N, Tsutsumi M, Arisawa T. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(26):8393–8406. doi:10.3748/wjg.v20.i26.839325024597
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik RA, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.84712324669
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671. doi:10.1164/rccm.201104-0597OC21680942
   PubMed Web of Science ®Google Scholar
• Chou K-T, Su K-C, Huang S-F, et al. Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD. Lung. 2014;192(4):499–504. doi:10.1007/s00408-014-9591-824816967
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Gómez FP, Benet M, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax. 2011;66(5):430–437. doi:10.1136/thx.2010.15448421177668
   PubMed Web of Science ®Google Scholar
• Vozoris NT, O’Donnell DE. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J. 2012;19(3):e18–24. doi:10.1155/2012/73261822679617
   PubMed Web of Science ®Google Scholar
• García-Rio F, Soriano JB, Miravitlles M, et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS ONE. 2014;9(8):e105220. doi:10.1371/journal.pone.010522025153331
   PubMed Web of Science ®Google Scholar